
Best practices for development of pediatric medicines in the EU
What became evident with the introduction of the Paediatric Investigation Plan (PIP) procedure in Europe is that Regulatory Experts need to keep a careful eye on all product development activities ongoing and understand how they might interact with the (potential) PIP. Here are some best practice tips for you to consider when thinking or working on your next PIP: Time constraints One of the most common tasks we worked on is a detailed strategic planning related to development